Cargando…

Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia

The genetic polymorphisms of X-ray repair cross complementing group 1 (XRCC1), X-ray repair cross complementing group 3 (XRCC3), and xeroderma pigmentosum complementation group D (XPD) repair genes may lead to genetic instability and leukemogenesis. The purpose of the study was to evaluate the assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bănescu, Claudia, Trifa, Adrian P., Demian, Smaranda, Benedek Lazar, Erzsebeth, Dima, Delia, Duicu, Carmen, Dobreanu, Minodora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052066/
https://www.ncbi.nlm.nih.gov/pubmed/24955348
http://dx.doi.org/10.1155/2014/213790
_version_ 1782320180805763072
author Bănescu, Claudia
Trifa, Adrian P.
Demian, Smaranda
Benedek Lazar, Erzsebeth
Dima, Delia
Duicu, Carmen
Dobreanu, Minodora
author_facet Bănescu, Claudia
Trifa, Adrian P.
Demian, Smaranda
Benedek Lazar, Erzsebeth
Dima, Delia
Duicu, Carmen
Dobreanu, Minodora
author_sort Bănescu, Claudia
collection PubMed
description The genetic polymorphisms of X-ray repair cross complementing group 1 (XRCC1), X-ray repair cross complementing group 3 (XRCC3), and xeroderma pigmentosum complementation group D (XPD) repair genes may lead to genetic instability and leukemogenesis. The purpose of the study was to evaluate the association between XRCC1 Arg399Gln, Arg280His and Arg194Trp, XRCC3 Thr241Met, and XPD Lys751Gln polymorphisms and the risk of developing CML in Romanian patients. A total of 156 patients diagnosed with CML and 180 healthy controls were included in this study. We found no association between CML and XRCC1 or XRCC3 variant genotypes in any of the investigated cases. A significant difference was observed in the variant genotype frequencies of the XPD Lys751Gln polymorphism between the patients with CML and control group (for variant homozygous genotypes, OR = 2.37; 95% CI = 1.20–4.67; P value = 0.016 and for combined heterozygous and variant homozygous genotypes, OR = 1.72; 95% CI = 1.10–2.69; P value = 0.019). This was also observed when analyzing the variant 751Gln allele (OR = 1.54; 95% CI = 1.13–2.11; P value = 0.008). Our results suggest that the XPD Lys751Gln variant genotype increases the risk of CML.
format Online
Article
Text
id pubmed-4052066
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40520662014-06-22 Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia Bănescu, Claudia Trifa, Adrian P. Demian, Smaranda Benedek Lazar, Erzsebeth Dima, Delia Duicu, Carmen Dobreanu, Minodora Biomed Res Int Research Article The genetic polymorphisms of X-ray repair cross complementing group 1 (XRCC1), X-ray repair cross complementing group 3 (XRCC3), and xeroderma pigmentosum complementation group D (XPD) repair genes may lead to genetic instability and leukemogenesis. The purpose of the study was to evaluate the association between XRCC1 Arg399Gln, Arg280His and Arg194Trp, XRCC3 Thr241Met, and XPD Lys751Gln polymorphisms and the risk of developing CML in Romanian patients. A total of 156 patients diagnosed with CML and 180 healthy controls were included in this study. We found no association between CML and XRCC1 or XRCC3 variant genotypes in any of the investigated cases. A significant difference was observed in the variant genotype frequencies of the XPD Lys751Gln polymorphism between the patients with CML and control group (for variant homozygous genotypes, OR = 2.37; 95% CI = 1.20–4.67; P value = 0.016 and for combined heterozygous and variant homozygous genotypes, OR = 1.72; 95% CI = 1.10–2.69; P value = 0.019). This was also observed when analyzing the variant 751Gln allele (OR = 1.54; 95% CI = 1.13–2.11; P value = 0.008). Our results suggest that the XPD Lys751Gln variant genotype increases the risk of CML. Hindawi Publishing Corporation 2014 2014-05-15 /pmc/articles/PMC4052066/ /pubmed/24955348 http://dx.doi.org/10.1155/2014/213790 Text en Copyright © 2014 Claudia Bănescu et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bănescu, Claudia
Trifa, Adrian P.
Demian, Smaranda
Benedek Lazar, Erzsebeth
Dima, Delia
Duicu, Carmen
Dobreanu, Minodora
Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
title Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
title_full Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
title_fullStr Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
title_full_unstemmed Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
title_short Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
title_sort polymorphism of xrcc1, xrcc3, and xpd genes and risk of chronic myeloid leukemia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052066/
https://www.ncbi.nlm.nih.gov/pubmed/24955348
http://dx.doi.org/10.1155/2014/213790
work_keys_str_mv AT banescuclaudia polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia
AT trifaadrianp polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia
AT demiansmaranda polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia
AT benedeklazarerzsebeth polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia
AT dimadelia polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia
AT duicucarmen polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia
AT dobreanuminodora polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia